Management of Thyroid Disease in Pregnancy

Hyperthyroidism Management

• The American College of Obstetricians and Gynecologists recommends using propylthiouracil (PTU) exclusively during the first trimester, then switching to methimazole for the second and third trimesters to minimize both congenital malformations and maternal hepatotoxicity 1, 2, 3
• The goal is to maintain free T4 or free thyroxine index (FTI) in the high-normal range using the lowest possible thioamide dosage, as recommended by the American Academy of Family Physicians 4, 1, 2
• Check free T4 or FTI every 2-4 weeks to adjust medication dosage, as suggested by the American Academy of Family Physicians 4, 1, 2, 3
• Once stable, check TSH every trimester, according to the American College of Obstetricians and Gynecologists 3
• Monitor for agranulocytosis (presents with sore throat and fever) - if these symptoms develop, obtain complete blood count immediately and discontinue the thioamide, as recommended by the American Academy of Family Physicians 4, 1
• Beta-blockers (e.g., propranolol) can temporarily manage symptoms like tremors and palpitations until thioamide therapy reduces thyroid hormone levels, as suggested by the American Academy of Family Physicians 4, 1
• Monitor fetal heart rate and growth in women with Graves' disease, according to the American College of Obstetricians and Gynecologists 4, 3
• Hyperemesis gravidarum with biochemical hyperthyroidism rarely requires treatment unless other clinical signs of hyperthyroidism are present, as recommended by the American College of Obstetricians and Gynecologists 1, 3
• Thyroid storm is a medical emergency requiring immediate treatment with PTU or methimazole, potassium/sodium iodide solutions, dexamethasone, phenobarbital, and supportive care without waiting for laboratory confirmation, according to the American College of Obstetricians and Gynecologists 1, 3
• Thyroidectomy is reserved only for women who do not respond to thioamide therapy or develop severe drug intolerance (agranulocytosis, severe hepatotoxicity); if necessary, perform during second trimester, as suggested by the American College of Obstetricians and Gynecologists 1, 3
• Radioactive iodine (I-131) is absolutely contraindicated during pregnancy as it causes fetal thyroid ablation, according to the American College of Obstetricians and Gynecologists 1, 3
• Women must wait four months after I-131 treatment before breastfeeding, as recommended by the American College of Obstetricians and Gynecologists 1
• Untreated or inadequately treated hyperthyroidism increases risks of severe preeclampsia, preterm delivery, heart failure, miscarriage, and low birth weight, according to the American College of Obstetricians and Gynecologists 2, 3

Hypothyroidism Management

• The American Academy of Family Physicians recommends treating all pregnant women with elevated TSH using levothyroxine to restore TSH to trimester-specific reference ranges, as untreated hypothyroidism increases risks of preeclampsia, low birth weight, and neuropsychological defects in offspring 4, 2
• Untreated maternal hypothyroidism increases risk of preeclampsia, according to the American Academy of Family Physicians 4
• Maternal hypothyroidism from iodine deficiency increases risk of congenital cretinism (growth failure, mental retardation, neuropsychological defects), as suggested by the American Academy of Family Physicians 4
• Inadequate treatment is associated with low birth weight in neonates, according to the American Academy of Family Physicians 4

Postpartum Considerations

• Inform the newborn's physician about maternal thyroid disease (both hyperthyroidism and hypothyroidism) due to risk of neonatal thyroid dysfunction, as recommended by the American Academy of Family Physicians 4, 2, 3
• Women treated with PTU or methimazole can safely breastfeed, according to the American Academy of Family Physicians 4, 2
• Monitor for postpartum thyroiditis in women with history of thyroid dysfunction, as suggested by the American College of Obstetricians and Gynecologists 3

Critical Pitfalls to Avoid

• Failing to switch from PTU to methimazole after first trimester increases risk of maternal hepatotoxicity, according to the American College of Obstetricians and Gynecologists 2
• Using radioactive iodine during pregnancy causes fetal thyroid ablation, as recommended by the American College of Obstetricians and Gynecologists 1, 3

Management of Gestational Thyroid Disease – Evidence‑Based Recommendations

Hyperthyroidism Emergency (Thyroid Storm)

• In pregnant patients experiencing thyroid storm, immediate therapy should include a thioamide (propylthiouracil or methimazole), potassium or sodium iodide solutions, dexamethasone, phenobarbital, and supportive measures; delivery should be avoided unless absolutely necessary. [American Family Physician] 5

Surgical Management of Refractory Hyperthyroidism

• Thyroidectomy is indicated only for pregnant women who fail to achieve control with thioamide drugs or develop severe drug intolerance (e.g., agranulocytosis, marked hepatotoxicity). When surgery is required, it should be performed in the second trimester to minimize fetal risk. [American Family Physician] 5

Radioactive Iodine (I‑131) Contraindications

• Administration of radioactive iodine is absolutely contraindicated throughout pregnancy because it causes fetal thyroid ablation.
• Women who have received I‑131 must wait at least four months before initiating breastfeeding to prevent infant exposure. [American Family Physician] 5

Post‑partum Thyroiditis

• Diagnosis of post‑partum thyroiditis in women with a history of thyroid disease is made by the appearance of a new abnormal serum TSH or free T4 level after delivery.
• The likelihood of progressing to permanent hypothyroidism is highest in patients who exhibit the greatest elevations in TSH and have positive antithyroid peroxidase antibodies. [American Family Physician] 5

Thyroid Nodules and Cancer in Pregnancy

• All thyroid nodules identified during pregnancy should be evaluated, as approximately 40 % prove to be malignant. [American Family Physician] 5
• When surgical removal is indicated for a malignant or suspicious nodule, thyroidectomy should be scheduled in the second trimester to balance maternal and fetal safety. [American Family Physician] 5
• Radioactive iodine therapy (I‑131) must be deferred until after delivery; it should not be administered during pregnancy. [American Family Physician] 5

Management of Thyroid Disease in Term Pregnant Women in Active Labor

Assessment of Thyroid Status in Labor

• Clinical evaluation shows no features of thyroid storm (no fever, normal heart rate, no altered mental status, no tremor, no palpitations, and stable blood pressure), indicating the patient is hemodynamically stable. 6
• Laboratory assessment reveals a suppressed TSH but free T3 and free T4 within their reference ranges, demonstrating biochemical control and absence of overt thyrotoxicosis. 6

Management of Labor When Thyroid Storm Is Absent

• In the absence of thyroid storm, antithyroid medication should not be initiated during active labor; delivery should proceed without delay. 6
• Initiating methimazole at this stage would not achieve a therapeutic reduction in circulating thyroid hormones before birth, as antithyroid drugs require several days to weeks to become effective. (Implicit from the above guidance)

Post‑Partum Monitoring and Therapy

• After delivery, thyroid function should be re‑checked within 1–2 weeks; if abnormal, methimazole may be restarted to maintain disease control. 6
• Post‑partum surveillance for thyroiditis is recommended; any new abnormal TSH or free T4 values after birth warrant further evaluation. 6

Thyroid Storm – Emergency Protocol (Applicable Only If Storm Occurs)

• Thyroid storm constitutes a medical emergency and must be treated immediately, without awaiting confirmatory laboratory results. 6
• Standard emergency therapy includes:
  
  • Propylthiouracil or methimazole
  • Saturated potassium iodide (or sodium iodide)
  • Dexamethasone
  • Phenobarbital (as needed)
  • Supportive measures (oxygen, antipyretics, hemodynamic monitoring)
    *These interventions are recommended to rapidly control hormone excess. 6
• Delivery should be avoided during an active thyroid storm unless it is absolutely necessary, because maternal and fetal outcomes are significantly worsened under storm conditions. 6

Methimazole Dosing and Monitoring in Pregnancy (After First Trimester)

Target Thyroid Goals

• Aim to keep free T4 (or free thyroxine index) in the high‑normal range using the lowest effective thioamide dose; the therapeutic intent is to maintain a mildly hyperthyroid state rather than full euthyroidism to avoid fetal thyroid suppression. [7][8]

Monitoring Schedule

• Check free T4 (or FTI) every 2–4 weeks throughout the second and third trimesters to guide dose adjustments of methimazole. 7

Minimum Effective Dose

• Use the minimum dose of methimazole required to achieve the high‑normal free T4 target, thereby limiting drug exposure while maintaining maternal control of hyperthyroidism. 7

Maternal Safety Monitoring

Agranulocytosis

• Early signs (e.g., sore throat, fever) should prompt an immediate complete blood count; if agranulocytosis is confirmed, discontinue the thioamide promptly. 7

Other Adverse Effects

• Clinicians should remain vigilant for hepatitis, vasculitis, and thrombocytopenia as possible thioamide‑related toxicities. 7

Fetal and Neonatal Considerations

• Transient fetal or neonatal thyroid suppression may occur but rarely necessitates treatment; informing the newborn’s care team is advisable. [7][8]

Adjunctive Symptom Management

• Short‑term beta‑blockers (e.g., propranolol) can be employed to control tremor and palpitations until methimazole normalizes thyroid hormone levels; they should be stopped once biochemical control is achieved. 7

Indications for Surgical Intervention

• Thyroidectomy is reserved for pregnant women who fail to achieve control with thioamides or develop severe drug intolerance (e.g., agranulocytosis, marked hepatotoxicity). 7

Breastfeeding Guidance

• Both propylthiouracil and methimazole are considered compatible with breastfeeding; mothers may safely nurse while on either medication. [7][8]

Risks of Inadequate or Excessive Treatment

Under‑treatment

• Insufficient control of maternal hyperthyroidism is associated with increased rates of severe preeclampsia, preterm delivery, heart failure, miscarriage, and low birth weight. 8

Over‑treatment

• Excessive dosing leading to maternal hypothyroidism can cause fetal thyroid suppression; therefore, the therapeutic target should remain the high‑normal free T4 range rather than a mid‑normal level. 7

Post‑Radioactive Iodine Precautions

• Women who have received radioactive iodine (I‑131) must wait at least four months before initiating breastfeeding to avoid fetal thyroid ablation. 7

Management of Hyperthyroidism in Pregnancy: Evidence‑Based Recommendations

Treatment Targets & Monitoring

• Aim for a high‑normal free T4 (or free thyroxine index) using the lowest effective dose of propylthiouracil to maintain mild maternal hyperthyroidism and avoid fetal thyroid suppression, as recommended by the American Family Physician. 9
• Re‑measure free T4 (or FTI) every 2–4 weeks to guide dose adjustments and maintain the target range. 9

Safety Monitoring – Hematologic Toxicity

• Watch for sore throat or fever, which may signal agranulocytosis; obtain an immediate complete blood count and discontinue propylthiouracil if confirmed. 9

Safety Monitoring – Hepatic & Other Toxicities

• Severe liver injury has been reported primarily with propylthiouracil doses ≥ 300 mg/day, but cases also occur at doses as low as 50 mg/day; clinicians should remain vigilant and consider switching to methimazole after the first trimester. 9
• Vasculitis and thrombocytopenia are additional possible thioamide‑related toxicities that require monitoring. 9

Adjunctive Symptom Management

• Use a beta‑blocker (e.g., propranolol) temporarily to control tremor, palpitations, and tachycardia until antithyroid therapy lowers hormone levels. 9

Fetal and Neonatal Considerations

• Transient fetal or neonatal thyroid suppression may occur with thioamide therapy but is usually self‑limited and rarely needs treatment. 9
• Notify the newborn’s physician of maternal Graves’ disease so appropriate neonatal thyroid monitoring can be arranged. 9

Indications for Surgery & Radioactive Iodine

• Thyroidectomy is reserved for patients who do not respond to thioamide therapy or who develop severe drug intolerance (e.g., agranulocytosis, marked hepatotoxicity). 9
• Radioactive iodine (I‑131) is absolutely contraindicated during pregnancy because it can ablate the fetal thyroid; breastfeeding must be delayed for at least four months after any I‑131 exposure. 9

Breastfeeding Guidance

• Both propylthiouracil and methimazole are compatible with breastfeeding, as only minimal drug amounts enter breast milk. 9

Practical Pitfalls to Avoid

• Do not target mid‑normal or low‑normal free T4 levels; maintaining a high‑normal range reduces the risk of fetal hypothyroidism. 9

Thyroid Storm Management in Pregnancy

Standard Treatment Protocol

Delivery Considerations

Clinical Presentation

Complications of Untreated Storm

Adjunctive Therapies

Thyroid Dysfunction as a Reversible Cause of Perinatal Mania

Epidemiology

• Post‑partum thyroiditis occurs in up to 11.5 % of women by six months after delivery and can precipitate an acute manic episode during its hypothyroid phase. 11

Clinical Overlap with Mania

• Thyroid storm may present with altered mental status (nervousness, restlessness, confusion), tachycardia, fever, and agitation— a symptom cluster that closely mimics acute mania. 11
• Hyperemesis gravidarum can be associated with biochemical hyperthyroidism (suppressed TSH, elevated free T4 index) that produces anxiety, tremor, and agitation, potentially being misinterpreted as hypomania. 11

Screening Recommendations (American College of Obstetricians and Gynecologists)

• The ACOG recommends thyroid screening (TSH and free T4) for pregnant women who have symptoms of thyroid disease, a personal or family history of thyroid disorder, thyroid nodules, or goiter; universal screening of all pregnant women is not currently endorsed. 11
• TSH and free T4 should also be evaluated in women who develop a goiter during pregnancy or the postpartum period, and may be considered for those with postpartum symptoms suggestive of thyroid dysfunction, recognizing that many symptoms overlap with normal postpartum physiology. 11

Weight‑Based Dosing of Methimazole in Pregnancy

Dosing Strategy

• For pregnant patients requiring methimazole, calculate the dose based on actual body weight using the same milligram‑per‑square‑meter (mg/m²) or milligram‑per‑kilogram (mg/kg) regimen that is employed for non‑pregnant adults, thereby ensuring appropriate drug exposure while maintaining disease control. 12